Bioluminescence imaging of Hepatitis C virus NS3/4A serine protease activity in cells and living animals

被引:22
作者
Wang, Licui [1 ]
Fu, Qiuxia [1 ]
Dong, Yafeng [1 ]
Zhou, Yong [1 ]
Jia, Shuaizheng [1 ]
Du, Juan [1 ]
Zhao, Fang [1 ]
Wang, Yingli [1 ]
Wang, Xiaohui [1 ]
Peng, Jianchun [1 ]
Yang, Shuhua [1 ]
Zhan, Linsheng [1 ]
机构
[1] Beijing Inst Transfus Med, Lab Blood Borne Virus, Beijing 100850, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
NS3/4A protease; Split firefly luciferase complementation strategy; In vivo imaging; RNA REPLICATION; IN-VIVO; INFECTION; CULTURE; ASSAY; INTERFERENCE; REPLICON; VIREMIA; LINES;
D O I
10.1016/j.antiviral.2010.04.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The lack of robust small animal models has been an obstacle to the screening of Hepatitis C virus (HCV) NS3/4A protease inhibitors in vivo. Here, we described a reporter assay system for in vivo noninvasive imaging of NS3/4A serine protease activity using split firefly luciferase complementation strategy. The reporter construct ANIuc(NS5A/B)BCluc constitutes the split N- and C-terminal fragments of luciferase, fused to interacting peptides, pepA and pepB, respectively, with an intervening HCV NS3/4A cleavage motif of NSSA/B. we proved that the reporter molecule could be proteolytically cleaved by NS3/4A at the NS5A/B motif in cells and living animals. Association of pepA and pepB brought inactive fragments of luciferase into close proximity, thereby restoring bioluminescence activity. The increase in luciferase activity was proportional to the dose of active NS3/4A protease. The ANIuc(NS5A/B)BCluc reporter also could be used to detect the activity of NS3/4A-specific shRNA and IFN-alpha. Therefore, the reporter assay system using split firefly luciferase complementation strategy should prove useful for evaluating NS3/4A protease activity in cells and living animals. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 50 条
  • [1] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
  • [2] Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probe
    Chuang, Chih-Hung
    Cheng, Tian-Lu
    Chen, Wei-Chun
    Huang, Yi-Jung
    Wang, Hsin-Ell
    Lo, Yen-Chen
    Hsieh, Yuan-Chin
    Lin, Wen-Wei
    Hsieh, Ya-Ju
    Ke, Chien-Chih
    Huang, Kang-Chieh
    Lee, Jin-Ching
    Huang, Ming-Yii
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [3] The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease
    Monteagudo, E.
    Fonsi, M.
    Chu, X.
    Bleasby, K.
    Evers, R.
    Pucci, V.
    Orsale, M. V.
    Cianetti, S.
    Ferrara, M.
    Harper, S.
    Laufer, R.
    Rowley, M.
    Summa, V.
    XENOBIOTICA, 2010, 40 (12) : 826 - 839
  • [4] On the steroids extracted from soft corals against the NS3/4A protease of hepatitis C virus
    Nguyen, Duy Phuong
    Nguyen, Ha Xuan
    Nguyen, Hue Van
    Dang, Linh Mai
    Nguyen, Minh Tho
    Nguyen, Hue Thi Minh
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2025, 136
  • [5] Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
    Parsy, Christophe
    Alexandre, Francois-Rene
    Brandt, Guillaume
    Caillet, Catherine
    Cappelle, Sylvie
    Chaves, Dominique
    Convard, Thierry
    Derock, Michel
    Gloux, Damien
    Griffon, Yann
    Lallos, Lisa
    Leroy, Frederic
    Liuzzi, Michel
    Loi, Anna-Giulia
    Moulat, Laure
    Musiu, Chiara
    Rahali, Houcine
    Roques, Virginie
    Seifer, Maria
    Standring, David
    Surleraux, Dominique
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4444 - 4449
  • [6] Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry
    Pillaiyar, Thanigaimalai
    Namasivayam, Vigneshwaran
    Manickam, Manoj
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (29) : 3404 - 3447
  • [7] Identification of Novel Small Molecule Inhibitors Against the NS3/4A Protease of Hepatitis C Virus Genotype 4a
    El-Sayed, Sara M.
    Ali, Mohamed A. M.
    El-Gendy, Bahaa El-Dien M.
    Dandash, Samar S.
    Issac, Yvette
    Saad, Reda
    Azab, Mohamed M.
    Mohamed, Mohamed R.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (37) : 4484 - 4491
  • [8] BI-201335 Treatment of Hepatitis C Virus Serine Protease NS3/Non-Structural Protein 4A (NS4A) Inhibitor
    Vachon, Marie-Louise
    DRUGS OF THE FUTURE, 2012, 37 (02) : 99 - 109
  • [9] Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3/4A serine protease
    Ren, Jinhong
    Ojeda, Isabel
    Patel, Maulik
    Johnson, Michael E.
    Lee, Hyun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 2349 - 2353
  • [10] Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
    Sheng, X. Christopher
    Appleby, Todd
    Butler, Thomas
    Cai, Ruby
    Chen, Xiaowu
    Cho, Aesop
    Clarke, Michael O.
    Cottell, Jeromy
    Delaney, William E.
    Doerffler, Edward
    Link, John
    Ji, Mingzhe
    Pakdaman, Rowchanak
    Pyun, Hyung-Jung
    Wu, Qiaoyin
    Xu, Jie
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2629 - 2634